Navigation Links
Russian Government Allocate Funds for HIV Vaccine Project

The Russian government will allocate one billion rubles (US$39.4 million) to develop a vaccine for HIV, Russia's chief doctor has said.

"The government will soon issue a decree allocating one billion rubles to boost current research for a HIV vaccine," Gennady Onishchenko said Thursday.

He said four leading Russian research institutes would take part in the three-year project, including the Vector State Research Center of Virology and Biotechnology in Novosibirsk, and the Institute of Immunology in Moscow.

Russia plans to double the number of infected people receiving antiretroviral therapy and to increase the number of those being tested for the virus from 21.7 million to 22 million, Onishchenko said.

Since 1987 when the first HIV case was reported in Russia, 388,871 cases have been registered, and women infected with the virus have given birth to 1,200 children. Among the most infected areas are the Moscow, Irkutsk, Samara, Orenburg, and Leningrad Regions.


'"/>




Page: 1

Related medicine news :

1. SARS reaches Russian Federation
2. Admission to Russian varsities is looking up
3. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
4. Russians face the death trap laid by alcoholism
5. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
6. High Rates of Latent TB Infection Found in Russian Health Workers
7. Fire at Russian Nursing Home Kills 63
8. Russian Health Care Marred by Corruption
9. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
10. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
11. Tanzanian Government Sanctions $20 Million For AIDS Arug
Post Your Comments:
Other Medicine News:Health News:Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 2Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 4Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 5Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 6Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 7Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 8Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 9Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 2Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 4Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 5Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 6Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 2Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 3